Filing Details

Accession Number:
0001144204-15-051838
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-25 19:21:10
Reporting Period:
2015-08-13
Filing Date:
2015-08-25
Accepted Time:
2015-08-25 19:21:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1379006 Nanoviricides Inc. NNVC Services-Commercial Physical & Biological Research (8731) 760674577
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1580568 Milton Boniuk C/O Nanoviricides, Inc.
1 Controls Drive
Shelton CT 06484
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2015-08-13 800 $1.25 1,606,191 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2015-08-14 8,594 $1.25 1,614,785 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2015-08-17 5,244 $1.25 1,620,029 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2015-08-18 2,547 $1.25 1,622,576 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2015-08-19 300 $1.25 1,622,876 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2015-08-20 2,662 $1.25 1,625,538 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2015-08-21 29,853 $1.25 1,655,391 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 1,083,963 shares of Common Stock and warrants to purchase an additional 571,428 shares of Common Stock held by the Reporting Person and his wife. Does not include: 942,859 shares of Common Stock, warrants to purchase an additional 285,714 shares of Common Stock or an indeterminate number of shares of Common Stock issuable upon conversion of debentures held by Boniuk Interests, Ltd.; 571,431 shares of Common Stock held by the Boniuk Charitable Foundation; or 50,000 shares of Common Stock, 952,381 shares of Common Stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture, or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible. Dr. Boniuk holds voting and dispositive power over the Boniuk Charitable Foundation, Boniuk Interests Ltd. and the Milton Boniuk IRA.